|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2004-1-5
|
|
pubmed:abstractText |
Mycophenolate mofetil (MMF) is routinely used as an immunosuppressant in a fixed daily dose regimen although it shows marked fluctuations in pharmacokinetics, and despite the fact that in regard to the active metabolite, mycophenolic acid (MPA), there is a well-known association between the pharmacokinetic parameters and clinical outcome.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0946-1965
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
470-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14703953-Area Under Curve,
pubmed-meshheading:14703953-Enzyme Inhibitors,
pubmed-meshheading:14703953-Female,
pubmed-meshheading:14703953-Graft Rejection,
pubmed-meshheading:14703953-Humans,
pubmed-meshheading:14703953-IMP Dehydrogenase,
pubmed-meshheading:14703953-Immunosuppressive Agents,
pubmed-meshheading:14703953-Kidney Transplantation,
pubmed-meshheading:14703953-Male,
pubmed-meshheading:14703953-Middle Aged,
pubmed-meshheading:14703953-Mycophenolic Acid,
pubmed-meshheading:14703953-Prodrugs,
pubmed-meshheading:14703953-Renal Dialysis
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients.
|
|
pubmed:affiliation |
Department of Internal Medicine, Nephrology, Charité Campus Mitte, Humboldt University, Berlin, Germany. petra.glander@charite.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
